BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30700132)

  • 1. Critical Role of SREBP-1c Large-VLDL Pathway in Environment-Induced Hypertriglyceridemia of Apo AV Deficiency.
    Takanashi M; Kimura T; Li C; Tanaka M; Matsuhashi A; Yoshida H; Noda A; Xu P; Takase S; Okazaki S; Iizuka Y; Kumagai H; Ikeda Y; Gotoda T; Takahashi M; Yagyu H; Ishibashi S; Yamauchi T; Kadowaki T; Liang G; Okazaki H
    Arterioscler Thromb Vasc Biol; 2019 Mar; 39(3):373-386. PubMed ID: 30700132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LXR-SREBP-1c-phospholipid transfer protein axis controls very low density lipoprotein (VLDL) particle size.
    Okazaki H; Goldstein JL; Brown MS; Liang G
    J Biol Chem; 2010 Feb; 285(9):6801-10. PubMed ID: 20037162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c.
    Jakel H; Nowak M; Moitrot E; Dehondt H; Hum DW; Pennacchio LA; Fruchart-Najib J; Fruchart JC
    J Biol Chem; 2004 Oct; 279(44):45462-9. PubMed ID: 15317819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by liver X receptor α through a sterol regulatory element-binding protein 1c-dependent mechanism in mice.
    Wu J; Wang C; Li S; Li S; Wang W; Li J; Chi Y; Yang H; Kong X; Zhou Y; Dong C; Wang F; Xu G; Yang J; Gustafsson JÅ; Guan Y
    Hepatology; 2013 Aug; 58(2):617-28. PubMed ID: 23348573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?
    Jakel H; Nowak M; Helleboid-Chapman A; Fruchart-Najib J; Fruchart JC
    Ann Med; 2006; 38(1):2-10. PubMed ID: 16448983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles.
    Grefhorst A; Elzinga BM; Voshol PJ; Plösch T; Kok T; Bloks VW; van der Sluijs FH; Havekes LM; Romijn JA; Verkade HJ; Kuipers F
    J Biol Chem; 2002 Sep; 277(37):34182-90. PubMed ID: 12097330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation.
    Chu K; Miyazaki M; Man WC; Ntambi JM
    Mol Cell Biol; 2006 Sep; 26(18):6786-98. PubMed ID: 16943421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deoxypodophyllotoxin in Anthriscus sylvestris alleviates fat accumulation in the liver via AMP-activated protein kinase, impeding SREBP-1c signal.
    Kim KY; Park KI; Lee SG; Baek SY; Lee EH; Kim SC; Kim SH; Park SG; Yu SN; Oh TW; Kim JH; Kim KJ; Ahn SC; Kim YW
    Chem Biol Interact; 2018 Oct; 294():151-157. PubMed ID: 30148990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c.
    Liang G; Yang J; Horton JD; Hammer RE; Goldstein JL; Brown MS
    J Biol Chem; 2002 Mar; 277(11):9520-8. PubMed ID: 11782483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.
    Basciano H; Miller A; Baker C; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G323-32. PubMed ID: 19497957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1.
    Jung YA; Kim HK; Bae KH; Seo HY; Kim HS; Jang BK; Jung GS; Lee IK; Kim MK; Park KG
    Exp Mol Med; 2014 Jan; 46(1):e73. PubMed ID: 24458133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR.
    Cha JY; Repa JJ
    J Biol Chem; 2007 Jan; 282(1):743-51. PubMed ID: 17107947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of hepatic fatty acid elongase 5 by LXRalpha-SREBP-1c.
    Qin Y; Dalen KT; Gustafsson JA; Nebb HI
    Biochim Biophys Acta; 2009 Feb; 1791(2):140-7. PubMed ID: 19136075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling.
    Yoshikawa T; Ide T; Shimano H; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Yatoh S; Kitamine T; Okazaki H; Tamura Y; Sekiya M; Takahashi A; Hasty AH; Sato R; Sone H; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1240-54. PubMed ID: 12730331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver X receptor α induces 17β-hydroxysteroid dehydrogenase-13 expression through SREBP-1c.
    Su W; Peng J; Li S; Dai YB; Wang CJ; Xu H; Gao M; Ruan XZ; Gustafsson JÅ; Guan YF; Zhang XY
    Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E357-E367. PubMed ID: 28270440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription.
    Yap F; Craddock L; Yang J
    Int J Biol Sci; 2011; 7(5):645-50. PubMed ID: 21647332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
    Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
    J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of SREBP-1c Requires SREBP-2-mediated Generation of a Sterol Ligand for LXR in Livers of Mice.
    Rong S; Cortés VA; Rashid S; Anderson NN; McDonald JG; Liang G; Moon YA; Hammer RE; Horton JD
    Elife; 2017 Feb; 6():. PubMed ID: 28244871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
    Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
    Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.
    Lee JM; Gang GT; Kim DK; Kim YD; Koo SH; Lee CH; Choi HS
    J Biol Chem; 2014 Jan; 289(2):1079-91. PubMed ID: 24265317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.